Clinical trials: Pacemaker Implantation
- Condition Pacemaker Implantation
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Heart Diseases, Cardiac Disease
CIED Implantation in Low BMI Patients
The primary objective is to demonstrate a better degree of healing at the incision site and a decrease in erosion with CanGaroo compared to control patients (no envelope, CIED alone).
- Trial name
- NCT04299282
- Testing
- CanGaroo
- Sponsor
- Elutia Inc.